Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs.
Barrera L, Cooreman E, de Dieu Iragena J, Drobniewski F, Duda P, Havelkova M, Hoffner S, Kam KM, Kim SJ, Labelle S, Lambregts K, Leimane V, Nunn P, Ramsay A, Raviglione M, Rich M, Ridderhof J, Rodrigues F, Rüsch-Gerdes S, Salfinger M, Scholten J, Selvakumar N, Shinnick T, Shul'gina M, Šķenders G, Sloutsky A, Small P, Van Deun A, Varaine F, Yagui M, Vincent V, Weyer K, Wright A, Zignol M. Barrera L, et al. Among authors: weyer k. Geneva: World Health Organization; 2008. Geneva: World Health Organization; 2008. PMID: 26290924 Free Books & Documents. Review.
Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance.
Zignol M, Dean AS, Falzon D, van Gemert W, Wright A, van Deun A, Portaels F, Laszlo A, Espinal MA, Pablos-Méndez A, Bloom A, Aziz MA, Weyer K, Jaramillo E, Nunn P, Floyd K, Raviglione MC. Zignol M, et al. Among authors: weyer k. N Engl J Med. 2016 Sep 15;375(11):1081-9. doi: 10.1056/NEJMsr1512438. N Engl J Med. 2016. PMID: 27626523 Free article. No abstract available.
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update.
Falzon D, Jaramillo E, Schünemann HJ, Arentz M, Bauer M, Bayona J, Blanc L, Caminero JA, Daley CL, Duncombe C, Fitzpatrick C, Gebhard A, Getahun H, Henkens M, Holtz TH, Keravec J, Keshavjee S, Khan AJ, Kulier R, Leimane V, Lienhardt C, Lu C, Mariandyshev A, Migliori GB, Mirzayev F, Mitnick CD, Nunn P, Nwagboniwe G, Oxlade O, Palmero D, Pavlinac P, Quelapio MI, Raviglione MC, Rich ML, Royce S, Rüsch-Gerdes S, Salakaia A, Sarin R, Sculier D, Varaine F, Vitoria M, Walson JL, Wares F, Weyer K, White RA, Zignol M. Falzon D, et al. Among authors: weyer k. Eur Respir J. 2011 Sep;38(3):516-28. doi: 10.1183/09031936.00073611. Epub 2011 Aug 4. Eur Respir J. 2011. PMID: 21828024 Free article.
Linezolid for extensively drug-resistant tuberculosis.
Jaramillo E, Weyer K, Raviglione M. Jaramillo E, et al. Among authors: weyer k. N Engl J Med. 2013 Jan 17;368(3):290. doi: 10.1056/NEJMc1214183. N Engl J Med. 2013. PMID: 23323917 No abstract available.
Drug-resistant tuberculosis: latest advances.
Falzon D, Weyer K, Raviglione MC. Falzon D, et al. Among authors: weyer k. Lancet Respir Med. 2013 Mar;1(1):e9-e10. doi: 10.1016/S2213-2600(12)70056-5. Epub 2013 Jan 14. Lancet Respir Med. 2013. PMID: 24321818 No abstract available.
156 results